Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Alzheimer's Disease

Free Subscription Articles published in Neurobiol Aging Retrieve available abstracts of 156 articles: HTML format

Single Articles

November 2025
1. ZIA G, Shahid SS, Yang HC, Gao S, et al
   Longitudinal non-linear changes in the microstructure of the hippocampal subfields in older adults.
   Neurobiol Aging. 2025;155:113-123.
   PubMed     Abstract available
   
   
   
2. LEONE R, Kobeleva X
   White matter hyperintensities contribute to early cortical thinning in addition to tau in aging.
   Neurobiol Aging. 2025;155:66-77.
   PubMed     Abstract available
   
   
   
3. MORADI E, Dahnke R, Imani V, Gaser C, et al
   Integrating plasma, MRI, and cognitive biomarkers for personalized prediction of decline across cognitive domains.
   Neurobiol Aging. 2025;155:53-65.
   PubMed     Abstract available
   
   
   
4. RILEY E, Cicero N, Swallow K, Anderson A, et al
   Blood oxygenation level-dependent responses in neuromodulatory nuclei and their associations with attention and memory across age groups.
   Neurobiol Aging. 2025;155:24-34.
   PubMed     Abstract available
   
   
   
5. RICHTER G, Kirsebom BE, Jarholm JA, Palhaugen L, et al
   Comparison of CSF neurofilament light chain and total tau as neurodegeneration markers: Associations with synaptic markers and cognitive outcomes.
   Neurobiol Aging. 2025;155:13-23.
   PubMed     Abstract available
   
   
   October 2025
6. MASHKANI SMH, Bishop D, Adlard PA, Mojtaba Golzan S, et al
   Zinc transporter proteins in the retina as potential biomarkers for staging early Alzheimer's disease: Comparative analysis in human and mouse models.
   Neurobiol Aging. 2025;157:26-35.
   PubMed     Abstract available
   
   
   September 2025
7. KUZU TD, Brinkmann E, Bonkhoff AK, Wunderle V, et al
   Apraxic deficits in Alzheimer's disease are associated with altered dynamic connectivity in praxis-related networks.
   Neurobiol Aging. 2025;157:36-47.
   PubMed     Abstract available
   
   
   
8. ANDERSON CL, Gross AL, Pettigrew C, Vazquez JP, et al
   Cognitive resilience in preclinical Alzheimer's disease: Higher NPTX2 and VGF levels are associated with reduced cognitive decline.
   Neurobiol Aging. 2025;156:133-142.
   PubMed     Abstract available
   
   
   August 2025
9. SMEGAL LF, Baillet M, Schneider C, Jutten RJ, et al
   Lower locus coeruleus integrity is associated with diminished practice effects in clinically unimpaired older individuals.
   Neurobiol Aging. 2025;152:13-24.
   PubMed     Abstract available
   
   
   July 2025
10. LAURELL AA, Shah SN, Rahmati M, O'Brien JT, et al
    Hypothalamic imaging in Alzheimer's disease and Lewy body dementia: A systematic review and meta-analysis.
    Neurobiol Aging. 2025;155:87-99.
    PubMed     Abstract available
    
    
    
11. O'NEILL N, Kurniansyah N, Zhu C, Olayinka OA, et al
    2988Multi-omic derived cell-type specific Alzheimer disease polygenic risk scores.
    Neurobiol Aging. 2025;155:44-52.
    PubMed     Abstract available
    
    
    
12. CHANDRA A, Levett BA, Waters S, Proitsi P, et al
    Evaluating the link between hearing loss and Alzheimer's disease neuropathology: A systematic review and meta-analysis.
    Neurobiol Aging. 2025;154:92-102.
    PubMed     Abstract available
    
    
    
13. NAJDEK C, Walle P, Flaig A, Ayral AM, et al
    Calpain and caspase regulate Abeta peptide production via cleavage of KINDLIN2 encoded by the AD-associated gene FERMT2.
    Neurobiol Aging. 2025;151:117-125.
    PubMed     Abstract available
    
    
    
14. PELEGRINI LNC, Manzine PR, Popolin CP, Dorta S, et al
    Higher soluble ADAM10 plasma levels are associated with decreased cognitive performance in older adults carrying APOEepsilon4.
    Neurobiol Aging. 2025;151:70-75.
    PubMed     Abstract available
    
    
    
15. LUO T, Vattathil SM, Lori A, Schneider JA, et al
    Brain microRNAs differentially expressed in age-related cerebral pathologies.
    Neurobiol Aging. 2025;151:42-53.
    PubMed     Abstract available
    
    
    June 2025
16. AKRADI M, Farzane-Daghigh T, Ebneabbasi A, Bi H, et al
    How is self-reported sleep-disordered breathing linked with biomarkers of Alzheimer's disease?
    Neurobiol Aging. 2025;154:16-24.
    PubMed     Abstract available
    
    
    
17. SREEPADA LP, Brown CA, Das SR, Yushkevich PA, et al
    Biological age acceleration in Alzheimer's disease modulates relative cortical to medial temporal lobe neurodegeneration.
    Neurobiol Aging. 2025;153:21-29.
    PubMed     Abstract available
    
    
    
18. ORCIANI C, Foret MK, Cuello AC, Do Carmo S, et al
    Long-term nucleus basalis cholinergic lesions alter the structure of cortical vasculature, astrocytic density and microglial activity in Wistar rats.
    Neurobiol Aging. 2025;150:132-145.
    PubMed     Abstract available
    
    
    May 2025
19. ALBERTAZZI A, Murphy C
    Brain activation in older adults during odor identification is related to ApoE, t-tau/Abeta(1-42), and hippocampal volume.
    Neurobiol Aging. 2025;149:44-53.
    PubMed     Abstract available
    
    
    
20. SANAMI S, Intzandt B, Huck J, Villeneuve S, et al
    Longitudinal relationships among cerebrospinal fluid biomarkers, cerebral blood flow, and grey matter volume in individuals with a familial history of Alzheimer's disease.
    Neurobiol Aging. 2025;152:43-53.
    PubMed     Abstract available
    
    
    April 2025
21. MCKEAN NE, Liu J, Rudiger SR, Kelly JM, et al
    Presenilin 1 hemizygosity has no overt deleterious phenotypic outcomes in sheep: Potential implications for therapeutic targets in Alzheimer's disease.
    Neurobiol Aging. 2025;152:25-33.
    PubMed     Abstract available
    
    
    
22. PAITEL ER, Pettigrew C, Moghekar A, Miller MI, et al
    Alzheimer's disease cerebrospinal fluid biomarker levels and APOE genetic status are associated with hippocampal-cerebellar functional connectivity.
    Neurobiol Aging. 2025;151:107-116.
    PubMed     Abstract available
    
    
    
23. ZAFARJAFARZADEH N, Feridouni E, Sobhani-Moghaddam S, Amini J, et al
    Dynamics and role of covalently-closed circular RNAs in Alzheimer's disease: A review of experimental and bioinformatics studies.
    Neurobiol Aging. 2025;151:54-69.
    PubMed     Abstract available
    
    
    
24. RUSSELL JK, Conley AC, Boyd BD, Begnoche JP, et al
    Differences in cholinergic terminal density in adults with Down syndrome compared to neurotypical controls measured by [(18)F]-fluoroethoxybenzovesamicol positron emission tomography imaging.
    Neurobiol Aging. 2025;148:50-60.
    PubMed     Abstract available
    
    
    
25. MCDERMOTT KE, Barnes CA
    Stability of locus coeruleus cell counts despite volume loss in cognitively impaired aged rhesus macaques.
    Neurobiol Aging. 2025;148:41-49.
    PubMed     Abstract available
    
    
    
26. HOJJATI SH, Butler TA, de Leon M, Gupta A, et al
    Inter-network functional connectivity increases by beta-amyloid and may facilitate the early stage of tau accumulation.
    Neurobiol Aging. 2025;148:16-26.
    PubMed     Abstract available
    
    
    March 2025
27. HRYBOUSKI S, Das SR, Xie L, Brown CA, et al
    BOLD amplitude correlates of preclinical Alzheimer's disease.
    Neurobiol Aging. 2025;150:157-171.
    PubMed     Abstract available
    
    
    
28. LAVROVA A, Pham NTT, Reid RI, Boeve BF, et al
    Relation of Alzheimer's disease-related TDP-43 proteinopathy to metrics from diffusion tensor imaging (DTI) and neurite orientation dispersion and density imaging (NODDI).
    Neurobiol Aging. 2025;150:97-108.
    PubMed     Abstract available
    
    
    
29. TREMBLAY SA, Nathan Spreng R, Wearn A, Alasmar Z, et al
    Sex and APOE4-specific links between cardiometabolic risk factors and white matter alterations in individuals with a family history of Alzheimer's disease.
    Neurobiol Aging. 2025;150:80-96.
    PubMed     Abstract available
    
    
    February 2025
30. QIANG Q, Skudder-Hill L, Toyota T, Huang Z, et al
    CSF alpha-synuclein aggregation is associated with APOE epsilon4 and progressive cognitive decline in Alzheimer's disease.
    Neurobiol Aging. 2025;150:9-18.
    PubMed     Abstract available
    
    
    
31. BUSSY A, Patel R, Parent O, Salaciak A, et al
    Exploring morphological and microstructural signatures across the Alzheimer's spectrum and risk factors.
    Neurobiol Aging. 2025;149:1-18.
    PubMed     Abstract available
    
    
    
32. MEUNIER-DUPERRAY L, Souchay C, Angel L, Salmon E, et al
    Exploring the domain specificity and the neural correlates of memory unawareness in Alzheimer's disease.
    Neurobiol Aging. 2025;148:61-70.
    PubMed     Abstract available
    
    
    January 2025
33. AL SHAMSI HSS, Gardener SL, Rainey-Smith SR, Pedrini S, et al
    The moderating effect of diet on the relationship between depressive symptoms and Alzheimer's disease-related blood-based biomarkers.
    Neurobiol Aging. 2025;147:213-222.
    PubMed     Abstract available
    
    
    
34. PAVULURI K, Huston J 3rd, Ehman RL, Manduca A, et al
    Brain mechanical properties predict longitudinal cognitive change in aging and Alzheimer's disease.
    Neurobiol Aging. 2025;147:203-212.
    PubMed     Abstract available
    
    
    
35. TAKAHASHI MKN, Paradela RS, Grinberg LT, Leite REP, et al
    Hypertension may associate with cerebral small vessel disease and infarcts through the pathway of intracranial atherosclerosis.
    Neurobiol Aging. 2025;145:84-95.
    PubMed     Abstract available
    
    
    
36. CHEN X, Juarez A, Mason S, Kobayashi S, et al
    Longitudinal relationships between Abeta and tau to executive function and memory in cognitively normal older adults.
    Neurobiol Aging. 2025;145:32-41.
    PubMed     Abstract available
    
    
    December 2024
37. CAPOGNA E, Sorensen O, Watne LO, Roe J, et al
    Subtypes of brain change in aging and their associations with cognition and Alzheimer's disease biomarkers.
    Neurobiol Aging. 2024;147:124-140.
    PubMed     Abstract available
    
    
    
38. WINFREE RL, Nolan E, Blennow K, Zetterberg H, et al
    Vascular endothelial growth factor receptor-1 (FLT1) interactions with amyloid-beta in Alzheimer's disease: A putative biomarker of amyloid-induced vascular damage.
    Neurobiol Aging. 2024;147:141-149.
    PubMed     Abstract available
    
    
    
39. RODRIGUES B, Ventura E, Moreira P, Resende R, et al
    New low-dose curcumin derivative with therapeutic potential in Alzheimer's disease: Results from an in vitro and in vivo study in mice.
    Neurobiol Aging. 2024;147:105-123.
    PubMed     Abstract available
    
    
    
40. VERONELLI L, Tosi G, Romano D
    Modeling functional loss in Alzheimer's Disease through cognitive reserve and cognitive state: A panel data longitudinal study.
    Neurobiol Aging. 2024;147:60-67.
    PubMed     Abstract available
    
    
    
41. BERNARDO AM, Marcotte M, Wong K, Sharmin D, et al
    Procognitive and neurotrophic benefits of alpha5-GABA-A receptor positive allosteric modulation in a beta-amyloid deposition mouse model of Alzheimer's disease pathology.
    Neurobiol Aging. 2024;147:49-59.
    PubMed     Abstract available
    
    
    
42. PIEVANI M, Ribaldi F, Toussas K, Da Costa S, et al
    Resting-state functional connectivity abnormalities in subjective cognitive decline: A 7T MRI study.
    Neurobiol Aging. 2024;144:104-113.
    PubMed     Abstract available
    
    
    
43. DENG F, Dounavi ME, Plini ERG, Ritchie K, et al
    Cardiovascular risk of dementia is associated with brain-behaviour changes in cognitively healthy, middle-aged individuals.
    Neurobiol Aging. 2024;144:78-92.
    PubMed     Abstract available
    
    
    
44. ALSEGIANI AS, Shah ZA
    Age-dependent sex differences in cofilin1 pathway (LIMK1/SSH1) and its association with AD biomarkers after chronic systemic inflammation in mice.
    Neurobiol Aging. 2024;144:43-55.
    PubMed     Abstract available
    
    
    
45. BAMFORD AR, Adams JN, Kim S, McMillan LC, et al
    The amyloid beta 42/38 ratio as a plasma biomarker of early memory deficits in cognitively unimpaired older adults.
    Neurobiol Aging. 2024;144:12-18.
    PubMed     Abstract available
    
    
    November 2024
46. DUTT S, Bachman SL, Dahl MJ, Li Y, et al
    Locus coeruleus MRI contrast, cerebral perfusion, and plasma Alzheimer's disease biomarkers in older adults.
    Neurobiol Aging. 2024;147:12-21.
    PubMed     Abstract available
    
    
    
47. DENKINGER M, Baker S, Harrison TM, Chadwick T, et al
    Cross-sectional and longitudinal relationships among blood-brain barrier disruption, Alzheimer's disease biomarkers, and cognition in cognitively normal older adults.
    Neurobiol Aging. 2024;146:15-23.
    PubMed     Abstract available
    
    
    
48. SORDO L, Ubele MF, Boaz KA, Mefford JL, et al
    Calcineurin/NFAT inhibitors maintain cognition in a preclinical prevention study in an aging canine model of Alzheimer disease.
    Neurobiol Aging. 2024;146:1-14.
    PubMed     Abstract available
    
    
    
49. YE Z, Pan Y, McCoy RG, Bi C, et al
    Contrasting association pattern of plasma low-density lipoprotein with white matter integrity in APOE4 carriers versus non-carriers.
    Neurobiol Aging. 2024;143:41-52.
    PubMed     Abstract available
    
    
    
50. BEER S, Elmenhorst D, Bischof GN, Ramirez A, et al
    Explainable artificial intelligence identifies an AQP4 polymorphism-based risk score associated with brain amyloid burden.
    Neurobiol Aging. 2024;143:19-29.
    PubMed     Abstract available
    
    
    October 2024
51. LU W, Shue F, Kurti A, Jeevaratnam S, et al
    Amyloid pathology and cognitive impairment in hAbeta-KI and APP(SAA)-KI mouse models of Alzheimer's disease.
    Neurobiol Aging. 2024;145:13-23.
    PubMed     Abstract available
    
    
    
52. DAVIES-JENKINS CW, Workman CI, Hupfeld KE, Zollner HJ, et al
    Multimodal investigation of neuropathology and neurometabolites in mild cognitive impairment and late-life depression with (11)C-PiB beta-amyloid PET and 7T magnetic resonance spectroscopy.
    Neurobiol Aging. 2024;142:27-40.
    PubMed     Abstract available
    
    
    September 2024
53. MACEDO AC, Therriault J, Tissot C, Aumont E, et al
    Modeling the progression of neuropsychiatric symptoms in Alzheimer's disease with PET-based Braak staging.
    Neurobiol Aging. 2024;144:127-137.
    PubMed     Abstract available
    
    
    
54. GAUTIER MK, Kelley CM, Lee SH, Mufson EJ, et al
    Maternal choline supplementation rescues early endosome pathology in basal forebrain cholinergic neurons in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease.
    Neurobiol Aging. 2024;144:30-42.
    PubMed     Abstract available
    
    
    
55. JIMENEZ-BALADO J, Habeck C, Stern Y, Eich T, et al
    The relationship between cortical thickness and white matter hyperintensities in mid to late life.
    Neurobiol Aging. 2024;141:129-139.
    PubMed     Abstract available
    
    
    
56. KARIM HT, Lee S, Gerlach A, Stinley M, et al
    Hippocampal subfield volume in older adults with and without mild cognitive impairment: Effects of worry and cognitive reappraisal.
    Neurobiol Aging. 2024;141:55-65.
    PubMed     Abstract available
    
    
    August 2024
57. PEREZ-MILLAN A, Thirion B, Falgas N, Borrego-Ecija S, et al
    Beyond group classification: Probabilistic differential diagnosis of frontotemporal dementia and Alzheimer's disease with MRI and CSF biomarkers.
    Neurobiol Aging. 2024;144:1-11.
    PubMed     Abstract available
    
    
    
58. QUARESIMA V, Pilotto A, Trasciatti C, Tolassi C, et al
    Plasma p-tau181 and amyloid markers in Alzheimer's disease: A comparison between Lumipulse and SIMOA.
    Neurobiol Aging. 2024;143:30-40.
    PubMed     Abstract available
    
    
    
59. CAVALLARI M, Touroutoglou A, Katsumi Y, Fong TG, et al
    Relationship between cortical brain atrophy, delirium, and long-term cognitive decline in older surgical patients.
    Neurobiol Aging. 2024;140:130-139.
    PubMed     Abstract available
    
    
    
60. LIBRI I, Silvestri C, Caratozzolo S, Alberici A, et al
    Association of APOE genotype with blood-brain barrier permeability in neurodegenerative disorders.
    Neurobiol Aging. 2024;140:33-40.
    PubMed     Abstract available
    
    
    July 2024
61. KAPOOR A, Dutt S, Alitin JPM, Sible IJ, et al
    Older adults with reduced cerebrovascular reactivity exhibit high white matter hyperintensity burden.
    Neurobiol Aging. 2024;139:5-10.
    PubMed     Abstract available
    
    
    June 2024
62. DE AVILA C, Suazo C, Nolz J, Nicholas Cochran J, et al
    Reduced PIN1 expression in neocortical and limbic brain regions in female Alzheimer's patients correlates with cognitive and neuropathological phenotypes.
    Neurobiol Aging. 2024;141:160-170.
    PubMed     Abstract available
    
    
    
63. CHATTERJEE A, Lee S, Diaz V, Saloner R, et al
    Associations of cerebrovascular disease and Alzheimer's disease pathology with cognitive decline: Analysis of the National Alzheimer's Coordinating Center Uniform Data Set.
    Neurobiol Aging. 2024;142:1-7.
    PubMed     Abstract available
    
    
    
64. VAN AMERONGEN S, Das S, Kamps S, Goossens J, et al
    Cerebrospinal fluid biomarkers and cognitive trajectories in patients with Alzheimer's disease and a history of traumatic brain injury.
    Neurobiol Aging. 2024;141:121-128.
    PubMed     Abstract available
    
    
    
65. BRANSBY L, Yassi N, Rosenich E, Buckley R, et al
    Associations between multidomain modifiable dementia risk factors with AD biomarkers and cognition in middle-aged and older adults.
    Neurobiol Aging. 2024;138:63-71.
    PubMed     Abstract available
    
    
    
66. RODRIGUEZ-FERNANDEZ B, Sanchez-Benavides G, Genius P, Minguillon C, et al
    Association between telomere length and cognitive function among cognitively unimpaired individuals at risk of Alzheimer's disease.
    Neurobiol Aging. 2024;141:140-150.
    PubMed     Abstract available
    
    
    May 2024
67. KNUDTZON SL, Nordengen K, Grontvedt GR, Jarholm J, et al
    Age-adjusted CSF t-tau and NfL do not improve diagnostic accuracy for prodromal Alzheimer's disease.
    Neurobiol Aging. 2024;141:74-84.
    PubMed     Abstract available
    
    
    
68. LIU R, Li JZ, Song JK, Zhou D, et al
    Corrigendum to: "Pinocembrin improves cognition and protects the neurovascular unit in Alzheimer related deficits" [Neurobiol. Aging 35 (2014) 1275-1285].
    Neurobiol Aging. 2024 May 22:S0197-4580(24)00101.
    PubMed    
    
    
    
69. YANG Q, Zhou X, Ma T
    Isoform-specific effects of neuronal inhibition of AMPK catalytic subunit on LTD impairments in a mouse model of Alzheimer's disease.
    Neurobiol Aging. 2024;140:116-121.
    PubMed     Abstract available
    
    
    
70. BERNOCCHI F, Bonomi CG, Assogna M, Moreschini A, et al
    Astrocytic-derived vascular remodeling factors are independently associated with blood brain barrier permeability in Alzheimer's disease.
    Neurobiol Aging. 2024;141:66-73.
    PubMed     Abstract available
    
    
    
71. LOPEZ S, Hampel H, Chiesa PA, Del Percio C, et al
    The association between posterior resting-state EEG alpha rhythms and functional MRI connectivity in older adults with subjective memory complaint.
    Neurobiol Aging. 2024;137:62-77.
    PubMed     Abstract available
    
    
    
72. POOLE VN, Ridwan AR, Arfanakis K, Dawe RJ, et al
    Associations of brain morphology with cortical proteins of cognitive resilience.
    Neurobiol Aging. 2024;137:1-7.
    PubMed     Abstract available
    
    
    April 2024
73. WINFREE RL, Erreger K, Phillips J, Seto M, et al
    Elevated protease-activated receptor 4 (PAR4) gene expression in Alzheimer's disease predicts cognitive decline.
    Neurobiol Aging. 2024;140:93-101.
    PubMed     Abstract available
    
    
    
74. JANG I, Li B, Rashid B, Jacoby J, et al
    Brain structural indicators of beta-amyloid neuropathology.
    Neurobiol Aging. 2024;136:157-170.
    PubMed     Abstract available
    
    
    
75. ROBINSON B, Bhamidi S, Dayan E
    The spatial distribution of coupling between tau and neurodegeneration in amyloid-beta positive mild cognitive impairment.
    Neurobiol Aging. 2024;136:70-77.
    PubMed     Abstract available
    
    
    
76. WHITMAN ET, Ryan CP, Abraham WC, Addae A, et al
    A blood biomarker of the pace of aging is associated with brain structure: replication across three cohorts.
    Neurobiol Aging. 2024;136:23-33.
    PubMed     Abstract available
    
    
    March 2024
77. NENCHA U, Rigoni I, Ribaldi F, Altomare D, et al
    Alterations in gamma frequency oscillations correlate with cortical tau deposition in Alzheimer's disease.
    Neurobiol Aging. 2024;139:1-4.
    PubMed     Abstract available
    
    
    
78. ROYSE SK, Snitz BE, Hill AV, Reese AC, et al
    Apolipoprotein E and Alzheimer's disease pathology in African American older adults.
    Neurobiol Aging. 2024;139:11-19.
    PubMed     Abstract available
    
    
    
79. SHAFIEE N, Fonov V, Dadar M, Spreng RN, et al
    Degeneration in Nucleus basalis of Meynert signals earliest stage of Alzheimer's disease progression.
    Neurobiol Aging. 2024;139:54-63.
    PubMed     Abstract available
    
    
    
80. INAGAKI R, Yamakuni T, Saito T, Saido TC, et al
    Preventive effect of propolis on cognitive decline in Alzheimer's disease model mice.
    Neurobiol Aging. 2024;139:20-29.
    PubMed     Abstract available
    
    
    
81. ALMEIDA FC, Jesus T, Coelho A, Quintas-Neves M, et al
    Psychosis in Alzheimer's disease is associated with specific changes in brain MRI volume, cognition and neuropathology.
    Neurobiol Aging. 2024;138:10-18.
    PubMed     Abstract available
    
    
    
82. TAGHVAEI M, Mechanic-Hamilton DJ, Sadaghiani S, Shakibajahromi B, et al
    Impact of white matter hyperintensities on structural connectivity and cognition in cognitively intact ADNI participants.
    Neurobiol Aging. 2024;135:79-90.
    PubMed     Abstract available
    
    
    
83. ZHANG YN, Chen XL, Guo LY, Jiang PR, et al
    Downregulation of peripheral luteinizing hormone rescues ovariectomy-associated cognitive deficits in APP/PS1 mice.
    Neurobiol Aging. 2024;135:60-69.
    PubMed     Abstract available
    
    
    
84. HEMMINGHYTH MS, Chwiszczuk LJ, Breitve MH, Gisladottir B, et al
    Cerebrospinal fluid neurofilament light chain mediates age-associated lower learning and memory in healthy adults.
    Neurobiol Aging. 2024;135:39-47.
    PubMed     Abstract available
    
    
    
85. BABILONI C, Noce G, Tucci F, Jakhar D, et al
    Poor reactivity of posterior electroencephalographic alpha rhythms during the eyes open condition in patients with dementia due to Parkinson's disease.
    Neurobiol Aging. 2024;135:1-14.
    PubMed     Abstract available
    
    
    February 2024
86. YILDIRIM E, Akturk T, Hanoglu L, Yener G, et al
    Lower oddball event-related EEG delta and theta responses in patients with dementia due to Parkinson's and Lewy body than Alzheimer's disease.
    Neurobiol Aging. 2024;137:78-93.
    PubMed     Abstract available
    
    
    
87. NAUDE J, Wang M, Leon R, Smith E, et al
    Tau-PET in early cortical Alzheimer brain regions in relation to mild behavioral impairment in older adults with either normal cognition or mild cognitive impairment.
    Neurobiol Aging. 2024;138:19-27.
    PubMed     Abstract available
    
    
    
88. AI M, Morris TP, Noriega de la Colina A, Thovinakere N, et al
    Midlife physical activity engagement is associated with later-life brain health.
    Neurobiol Aging. 2024;134:146-159.
    PubMed     Abstract available
    
    
    
89. BABILONI C, Jakhar D, Tucci F, Del Percio C, et al
    Resting state electroencephalographic alpha rhythms are sensitive to Alzheimer's disease mild cognitive impairment progression at a 6-month follow-up.
    Neurobiol Aging. 2024;137:19-37.
    PubMed     Abstract available
    
    
    January 2024
90. LAN F, Roquet D, Dalton MA, El-Omar H, et al
    Exploring graded profiles of hippocampal atrophy along the anterior-posterior axis in semantic dementia and Alzheimer's disease.
    Neurobiol Aging. 2024;135:70-78.
    PubMed     Abstract available
    
    
    
91. FERRARI-SOUZA JP, Brum WS, Hauschild LA, Da Ros LU, et al
    Vascular risk burden is a key player in the early progression of Alzheimer's disease.
    Neurobiol Aging. 2024;136:88-98.
    PubMed     Abstract available
    
    
    
92. CIAMPA CJ, Morin TM, Murphy A, Joie R, et al
    DAT1 and BDNF polymorphisms interact to predict Abeta and tau pathology.
    Neurobiol Aging. 2024;133:115-124.
    PubMed     Abstract available
    
    
    
93. HALE MR, Langhough R, Du L, Hermann BP, et al
    Associations between recall of proper names in story recall and CSF amyloid and tau in adults without cognitive impairment.
    Neurobiol Aging. 2024;133:87-98.
    PubMed     Abstract available
    
    
    
94. SOOD A, Capuano AW, Wilson RS, Barnes LL, et al
    Metformin, age-related cognitive decline, and brain pathology.
    Neurobiol Aging. 2024;133:99-106.
    PubMed     Abstract available
    
    
    
95. TWITTO-GREENBERG R, Liraz-Zaltsman S, Michaelson DM, Liraz O, et al
    9-cis beta-carotene-enriched diet significantly improved cognition and decreased Alzheimer's disease neuropathology and neuroinflammation in Alzheimer's disease-like mouse models.
    Neurobiol Aging. 2024;133:16-27.
    PubMed     Abstract available
    
    
    
96. SIMON SS, Varangis E, Lee S, Gu Y, et al
    In vivo tau is associated with change in memory and processing speed, but not reasoning, in cognitively unimpaired older adults.
    Neurobiol Aging. 2024;133:28-38.
    PubMed     Abstract available
    
    
    December 2023
97. LEVIN F, Grothe MJ, Dyrba M, Franzmeier N, et al
    Longitudinal trajectories of cognitive reserve in hypometabolic subtypes of Alzheimer's disease.
    Neurobiol Aging. 2023;135:26-38.
    PubMed     Abstract available
    
    
    
98. LAN G, Du J, Chen X, Wang Q, et al
    Association of APOE-epsilon4 and GAP-43-related presynaptic loss with beta-amyloid, tau, neurodegeneration, and cognitive decline.
    Neurobiol Aging. 2023;132:209-219.
    PubMed     Abstract available
    
    
    
99. QIU T, Hong H, Zeng Q, Luo X, et al
    Degeneration of cholinergic white matter pathways and nucleus basalis of Meynert in individuals with objective subtle cognitive impairment.
    Neurobiol Aging. 2023;132:198-208.
    PubMed     Abstract available
    
    
    
100. CATTERSON JH, Minkley L, Aspe S, Judd-Mole S, et al
     Protein retention in the endoplasmic reticulum rescues Abeta toxicity in Drosophila.
     Neurobiol Aging. 2023;132:154-174.
     PubMed     Abstract available
     
     
     
101. KAN CN, Huang X, Zhang L, Hilal S, et al
     Comorbid amyloid with cerebrovascular disease in domain-specific cognitive and neuropsychiatric disturbances: a cross-sectional memory clinic study.
     Neurobiol Aging. 2023;132:47-55.
     PubMed     Abstract available
     
     
     November 2023
102. CHIN KS, Holper S, Loveland P, Churilov L, et al
     Prevalence of cerebral microbleeds in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia: A systematic review and meta-analysis.
     Neurobiol Aging. 2023;134:74-83.
     PubMed     Abstract available
     
     
     
103. LI JQ, Song JH, Suckling J, Wang YJ, et al
     Disease trajectories in older adults with non-AD pathologic change and comparison with Alzheimer's disease pathophysiology: A longitudinal study.
     Neurobiol Aging. 2023;134:106-114.
     PubMed     Abstract available
     
     
     
104. ROCCATI E, Collins JM, Bindoff AD, Alty JE, et al
     Modifiable risk factors for dementia, cognition, and plasma phosphorylated tau 181 in a large-scale cohort of Australian older adults.
     Neurobiol Aging. 2023;131:106-114.
     PubMed     Abstract available
     
     
     
105. GREGORY S, Blennow K, Ritchie CW, Shannon OM, et al
     Mediterranean diet is associated with lower white matter lesion volume in Mediterranean cities and lower cerebrospinal fluid Abeta(42) in non-Mediterranean cities in the EPAD LCS cohort.
     Neurobiol Aging. 2023;131:29-38.
     PubMed     Abstract available
     
     
     
106. ZENUNI H, Bovenzi R, Bissacco J, Grillo P, et al
     Clinical and neurochemical correlates of the APOE genotype in early-stage Parkinson's disease.
     Neurobiol Aging. 2023;131:24-28.
     PubMed     Abstract available
     
     
     
107. AKSNES M, Capogna E, Vidal-Pineiro D, Chaudhry FA, et al
     Matrix metalloproteinases are associated with brain atrophy in cognitively unimpaired individuals.
     Neurobiol Aging. 2023;131:11-23.
     PubMed     Abstract available
     
     
     October 2023
108. NUYTEMANS K, Rajabli F, Jean-Francois M, Kurup JT, et al
     Genetic analyses in multiplex families confirms chromosome 5q35 as a risk locus for Alzheimer's Disease in individuals of African Ancestry.
     Neurobiol Aging. 2023;133:125-133.
     PubMed     Abstract available
     
     
     
109. KANG S, Jeon S, Lee YG, Ye BS, et al
     Dopamine transporter positron emission tomography in patients with Alzheimer's disease with Lewy body disease features.
     Neurobiol Aging. 2023;134:57-65.
     PubMed     Abstract available
     
     
     
110. LEE BN, Wang J, Hall MA, Kim D, et al
     Sex modifies effects of imaging and CSF biomarkers on cognitive and functional outcomes: a study of Alzheimer's disease.
     Neurobiol Aging. 2023;133:67-77.
     PubMed     Abstract available
     
     
     
111. LI J, Chen D, Liu H, Xi Y, et al
     Identifying potential genetic epistasis implicated in Alzheimer's disease via detection of SNP-SNP interaction on quantitative trait CSF Abeta(42).
     Neurobiol Aging. 2023;134:84-93.
     PubMed     Abstract available
     
     
     
112. COUGHLAN G, DeSouza B, Zhukovsky P, Hornberger M, et al
     Spatial cognition is associated with levels of phosphorylated-tau and beta-amyloid in clinically normal older adults.
     Neurobiol Aging. 2023;130:124-134.
     PubMed     Abstract available
     
     
     
113. BEJIA I, Labidi J, Warniez A, Bayot M, et al
     Multi-approach comparative study of EEG patterns associated with the most common forms of dementia.
     Neurobiol Aging. 2023;130:30-39.
     PubMed     Abstract available
     
     
     
114. LIZIO R, Lopez S, Babiloni C, Del Percio C, et al
     Resting state EEG rhythms in different stages of chronic kidney disease with mild cognitive impairment.
     Neurobiol Aging. 2023;130:70-79.
     PubMed     Abstract available
     
     
     September 2023
115. ZHU M, Gu H, Bai H, Li Y, et al
     Role and molecular regulatory mechanisms of Hippo signaling pathway in Caenorhabditis elegans and mammalian cell models of Alzheimer's disease.
     Neurobiol Aging. 2023;134:9-20.
     PubMed     Abstract available
     
     
     
116. AERQIN Q, Chen XT, Ou YN, Ma YH, et al
     Associations between multimorbidity burden and Alzheimer's pathology in older adults without dementia: the CABLE study.
     Neurobiol Aging. 2023;134:1-8.
     PubMed     Abstract available
     
     
     
117. ORCIANI C, Do Carmo S, Foret MK, Hall H, et al
     Early treatment with an M1 and sigma-1 receptor agonist prevents cognitive decline in a transgenic rat model displaying Alzheimer-like amyloid pathology.
     Neurobiol Aging. 2023;132:220-232.
     PubMed     Abstract available
     
     
     
118. HONEA RA, Hunt S, Lepping RJ, Vidoni ED, et al
     Alzheimer's disease cortical morphological phenotypes are associated with TOMM40'523-APOE haplotypes.
     Neurobiol Aging. 2023;132:131-144.
     PubMed     Abstract available
     
     
     
119. XIA Y, Maruff P, Dore V, Bourgeat P, et al
     Longitudinal trajectories of basal forebrain volume in normal aging and Alzheimer's disease.
     Neurobiol Aging. 2023;132:120-130.
     PubMed     Abstract available
     
     
     
120. LIM YY, Yassi N, Bransby L, Ayton S, et al
     CSF Abeta(42) and tau biomarkers in cognitively unimpaired Abeta- middle-aged and older APOE epsilon4 carriers.
     Neurobiol Aging. 2023;129:209-218.
     PubMed     Abstract available
     
     
     
121. ALCHERA N, Garibotto V, Tomczyk S, Treyer V, et al
     Patterns of amyloid accumulation in amyloid-negative cases.
     Neurobiol Aging. 2023;129:99-108.
     PubMed     Abstract available
     
     
     
122. NIKSERESHT G, Evia AM, Nag S, Leurgans SE, et al
     Neuropathologic correlates of cerebral microbleeds in community-based older adults.
     Neurobiol Aging. 2023;129:89-98.
     PubMed     Abstract available
     
     
     
123. JONES KT, Gallen CL, Ostrand AE, Rojas JC, et al
     Gamma neuromodulation improves episodic memory and its associated network in amnestic mild cognitive impairment: a pilot study.
     Neurobiol Aging. 2023;129:72-88.
     PubMed     Abstract available
     
     
     
124. RENNIE A, Ekman U, Wallert J, Muehlboeck JS, et al
     Comparing three neuropsychological subgrouping approaches in subjective and mild cognitive impairment from a naturalistic multicenter study.
     Neurobiol Aging. 2023;129:41-49.
     PubMed     Abstract available
     
     
     August 2023
125. HOY KE, Emonson MRL, Bailey NW, Rogers C, et al
     Gamma connectivity predicts response to intermittent theta burst stimulation in Alzheimer's disease: a randomized controlled trial.
     Neurobiol Aging. 2023;132:13-23.
     PubMed     Abstract available
     
     
     
126. TUBI MA, Wheeler K, Matsiyevskiy E, Hapenney M, et al
     White matter hyperintensity volume modifies the association between CSF vascular inflammatory biomarkers and regional FDG-PET along the Alzheimer's disease continuum.
     Neurobiol Aging. 2023;132:1-12.
     PubMed     Abstract available
     
     
     
127. MOALLEMIAN S, Salmon E, Bahri MA, Beliy N, et al
     Multimodal imaging of microstructural cerebral alterations and loss of synaptic density in Alzheimer's disease.
     Neurobiol Aging. 2023;132:24-35.
     PubMed     Abstract available
     
     
     
128. TERRACCIANO A, Walker K, An Y, Luchetti M, et al
     The association between personality and plasma biomarkers of astrogliosis and neuronal injury.
     Neurobiol Aging. 2023;128:65-73.
     PubMed     Abstract available
     
     
     
129. KAPOOR A, Gaubert A, Yew B, Jang JY, et al
     Enlarged perivascular spaces and plasma Abeta42/Abeta40 ratio in older adults without dementia.
     Neurobiol Aging. 2023;128:43-48.
     PubMed     Abstract available
     
     
     July 2023
130. COLMANT L, Bierbrauer A, Bellaali Y, Kunz L, et al
     Dissociating effects of aging and genetic risk of sporadic Alzheimer's disease on path integration.
     Neurobiol Aging. 2023;131:170-181.
     PubMed     Abstract available
     
     
     
131. GROECHEL RC, Tripodis Y, Alosco ML, Mez J, et al
     Biomarkers of Alzheimer's disease in Black and/or African American Alzheimer's Disease Neuroimaging Initiative (ADNI) participants.
     Neurobiol Aging. 2023;131:144-152.
     PubMed     Abstract available
     
     
     
132. CUKIER HN, Duarte CL, Laverde-Paz MJ, Simon SA, et al
     An Alzheimer's disease risk variant in TTC3 modifies the actin cytoskeleton organization and the PI3K-Akt signaling pathway in iPSC-derived forebrain neurons.
     Neurobiol Aging. 2023;131:182-195.
     PubMed     Abstract available
     
     
     
133. ISELLA V, Licciardo D, Rebecchi G, Ferri F, et al
     A cognitive marker for Alzheimer disease pathology in primary progressive aphasia? A validation study in the clinical setting.
     Neurobiol Aging. 2023;131:153-155.
     PubMed     Abstract available
     
     
     
134. SU Z, Zhang G, Li X, Zhang H, et al
     Inverse correlation between Alzheimer's disease and cancer from the perspective of hypoxia.
     Neurobiol Aging. 2023;131:59-73.
     PubMed     Abstract available
     
     
     
135. GROECHEL RC, Tripodis Y, Alosco ML, Mez J, et al
     Annualized changes in rate of amyloid deposition and neurodegeneration are greater in participants who become amyloid positive than those who remain amyloid negative.
     Neurobiol Aging. 2023;127:33-42.
     PubMed     Abstract available
     
     
     June 2023
136. SWINFORD CG, Risacher SL, Vosmeier A, Deardorff R, et al
     Amyloid and tau pathology are associated with cerebral blood flow in a mixed sample of nondemented older adults with and without vascular risk factors for Alzheimer's disease.
     Neurobiol Aging. 2023;130:103-113.
     PubMed     Abstract available
     
     
     
137. PAN F, Wang Y, Wang Y, Wang X, et al
     Sex and APOE genotype differences in amyloid deposition and cognitive performance along the Alzheimer's Continuum.
     Neurobiol Aging. 2023;130:84-92.
     PubMed     Abstract available
     
     
     
138. FRICK A, Besson G, Salmon E, Delhaye E, et al
     Perirhinal cortex is associated with fine-grained discrimination of conceptually confusable objects in Alzheimer's disease.
     Neurobiol Aging. 2023;130:1-11.
     PubMed     Abstract available
     
     
     
139. INAYAT S, McAllister BB, Chang H, Lacoursiere SG, et al
     Weak-hyperactive hippocampal CA1 neurons in the prodromal stage of Alzheimer's disease in hybrid App(NL-G-F/NL-G-F) x Thy1-GCaMP6s(+/-) mice suggest disrupted plasticity.
     Neurobiol Aging. 2023;130:154-171.
     PubMed     Abstract available
     
     
     
140. HOPKINS WD, Li X, Roberts N, Mulholland MM, et al
     Age differences in cortical thickness and their association with cognition in chimpanzee (Pan troglodytes).
     Neurobiol Aging. 2023;126:91-102.
     PubMed     Abstract available
     
     
     May 2023
141. FLORES-SANDOVAL AA, Davila-Perez P, Buss SS, Donohoe K, et al
     Spectral power ratio as a measure of EEG changes in mild cognitive impairment due to Alzheimer's disease: a case-control study.
     Neurobiol Aging. 2023;130:50-60.
     PubMed     Abstract available
     
     
     
142. SUN Z, Zhao C, Liu X, Zhang P, et al
     Mutation analysis of the ECE1 gene in late-onset Alzheimer's disease.
     Neurobiol Aging. 2023;129:58-61.
     PubMed     Abstract available
     
     
     
143. WILLIAMS ME, Elman JA, Bell TR, Dale AM, et al
     Higher cortical thickness/volume in Alzheimer's-related regions: protective factor or risk factor?
     Neurobiol Aging. 2023;129:185-194.
     PubMed     Abstract available
     
     
     
144. MIKKELSEN JD, Kaad S, Aripaka SS, Finsen B, et al
     Synaptic vesicle glycoprotein 2A (SV2A) levels in the cerebral cortex in patients with Alzheimer's disease: a radioligand binding study in postmortem brains.
     Neurobiol Aging. 2023;129:50-57.
     PubMed     Abstract available
     
     
     
145. WEIGAND AJ, Ortiz G, Walker KS, Galasko DR, et al
     APOE differentially moderates cerebrospinal fluid and plasma phosphorylated tau181 associations with multi-domain cognition.
     Neurobiol Aging. 2023;125:1-8.
     PubMed     Abstract available
     
     
     April 2023
146. PAPADATOS Z, Phillips NA
     Olfactory function reflects episodic memory performance and atrophy in the medial temporal lobe in individuals at risk for Alzheimer's disease.
     Neurobiol Aging. 2023;128:33-42.
     PubMed     Abstract available
     
     
     
147. SOTO PL, Young ME, DiMarco GM, George B, et al
     Longitudinal assessment of cognitive function in the APPswe/PS1dE9 mouse model of Alzheimer's-related beta-amyloidosis.
     Neurobiol Aging. 2023 Apr 2:S0197-4580(23)00062.
     PubMed     Abstract available
     
     
     March 2023
148. KASUGA K, Tsukie T, Kikuchi M, Tokutake T, et al
     The clinical application of optimized AT(N) classification in Alzheimer's clinical syndrome (ACS) and non-ACS conditions.
     Neurobiol Aging. 2023;127:23-32.
     PubMed     Abstract available
     
     
     
149. WIGHTMAN DP, Savage JE, Tissink E, Romero C, et al
     The genetic overlap between Alzheimer's disease, amyotrophic lateral sclerosis, Lewy body dementia, and Parkinson's disease.
     Neurobiol Aging. 2023 Mar 12:S0197-4580(23)00050.
     PubMed     Abstract available
     
     
     
150. NA H, Yang JB, Zhang Z, Gan Q, et al
     Peripheral apolipoprotein E proteins and their binding to LRP1 antagonize Alzheimer's disease pathogenesis in the brain during peripheral chronic inflammation.
     Neurobiol Aging. 2023;127:54-69.
     PubMed     Abstract available
     
     
     
151. KESZYCKI R, Rodriguez G, Dunn JT, Locci A, et al
     Characterization of apathy-like behaviors in the 5xFAD mouse model of Alzheimer's disease.
     Neurobiol Aging. 2023;126:113-122.
     PubMed     Abstract available
     
     
     February 2023
152. SUPIYEV A, Karlsson R, Wang Y, Koch E, et al
     Independent role of Alzheimer's disease genetics and C-reactive protein on cognitive ability in aging.
     Neurobiol Aging. 2023;126:103-112.
     PubMed     Abstract available
     
     
     
153. KIM BJ, Grossman M, Aleman TS, Song D, et al
     Retinal photoreceptor layer thickness has disease specificity and distinguishes predicted FTLD-Tau from biomarker-determined Alzheimer's disease.
     Neurobiol Aging. 2023;125:74-82.
     PubMed     Abstract available
     
     
     
154. KELBERMAN MA, Rorabaugh JM, Anderson CR, Marriott A, et al
     Age-dependent dysregulation of locus coeruleus firing in a transgenic rat model of Alzheimer's disease.
     Neurobiol Aging. 2023;125:98-108.
     PubMed     Abstract available
     
     
     January 2023
155. SETO M, Dumitrescu L, Mahoney ER, Sclafani AM, et al
     Multi-omic characterization of brain changes in the vascular endothelial growth factor family during aging and Alzheimer's disease.
     Neurobiol Aging. 2023;126:25-33.
     PubMed     Abstract available
     
     
     December 2022
156. ZHU M, Hou T, Jia L, Tan Q, et al
     Development and validation of a 13-gene signature associated with immune function for the detection of Alzheimer's disease.
     Neurobiol Aging. 2022;125:62-73.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.